Literature DB >> 22437821

The use of integrated and intelligent testing strategies in the prediction of toxic hazard and in risk assessment.

Michael Balls1, Robert D Combes, Nirmala Bhogal.   

Abstract

There is increasing concern that insurmountable differences between humans and laboratory animals limit the relevance and reliability for hazard identification and risk assessment purposes of animal data produced by traditional toxicity test procedures. A way forward is offered by the emerging new technologies, which can be directly applied to human material or even to human beings themselves. This promises to revolutionise the evaluation of the safety of chemicals and chemical products of various kinds and, in particular, pharmaceuticals. The available and developing technologies are summarised and it is emphasised that they will need to be used selectively, in integrated and intelligent testing strategies, which, in addition to being scientifically sound, must be manageable and affordable. Examples are given of proposed testing strategies for general chemicals, cosmetic ingredients, candidate pharmaceuticals, inhaled substances, nanoparticles and neurotoxicity.

Entities:  

Mesh:

Year:  2012        PMID: 22437821      PMCID: PMC7122993          DOI: 10.1007/978-1-4614-3055-1_13

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  59 in total

1.  A FRAME response to the Draft Report on Alternative (Non-animal) Methods for Cosmetics Testing: Current Status and Future Prospects--2010.

Authors:  Michael Balls; Richard Clothier
Journal:  Altern Lab Anim       Date:  2010-10       Impact factor: 1.303

Review 2.  Biomarkers of cardiovascular disease: molecular basis and practical considerations.

Authors:  Ramachandran S Vasan
Journal:  Circulation       Date:  2006-05-16       Impact factor: 29.690

3.  Proposed integrated decision-tree testing strategies for mutagenicity and carcinogenicity in relation to the EU REACH legislation.

Authors:  Robert Combes; Christina Grindon; Mark T D Cronin; David W Roberts; John Garrod
Journal:  Altern Lab Anim       Date:  2007-05       Impact factor: 1.303

Review 4.  In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling.

Authors:  S Ekins; J Mestres; B Testa
Journal:  Br J Pharmacol       Date:  2007-06-04       Impact factor: 8.739

5.  In vitro models of inhalation toxicity and disease. The report of a FRAME workshop.

Authors:  Kelly BéruBé; Michaela Aufderheide; Damien Breheny; Richard Clothier; Robert Combes; Rodger Duffin; Ben Forbes; Marianna Gaça; Alison Gray; Ian Hall; Michael Kelly; Michael Lethem; Manfred Liebsch; Leona Merolla; Jean-Paul Morin; JeanClare Seagrave; Melody A Swartz; Teresa D Tetley; Meera Umachandran
Journal:  Altern Lab Anim       Date:  2009-02       Impact factor: 1.303

6.  Overcoming barriers to validation of non-animal partial replacement methods/Integrated Testing Strategies: the report of an EPAA-ECVAM workshop.

Authors:  Agnieszka Kinsner-Ovaskainen; Zerrin Akkan; Silvia Casati; Sandra Coecke; Raffaella Corvi; Gianni Dal Negro; Jack De Bruijn; Odile De Silva; Laura Gribaldo; Claudius Griesinger; Joanna Jaworska; Joachim Kreysa; Gavin Maxwell; Pauline McNamee; Anna Price; Pilar Prieto; Roland Schubert; Luca Tosti; Andrew Worth; Valerie Zuang
Journal:  Altern Lab Anim       Date:  2009-09       Impact factor: 1.303

7.  The value and benefits of the International Conference on Harmonisation to drug regulatory authorities: advancing harmonization for better public health.

Authors:  J A Molzon; A Giaquinto; L Lindstrom; T Tominaga; M Ward; P Doerr; L Hunt; L Rago
Journal:  Clin Pharmacol Ther       Date:  2011-02-16       Impact factor: 6.875

8.  A step closer to complete chemical reprogramming for generating iPS cells.

Authors:  Aniruddh Solanki; Ki Bum Lee
Journal:  Chembiochem       Date:  2010-04-12       Impact factor: 3.164

9.  TGN1412: time to change the paradigm for the testing of new pharmaceuticals.

Authors:  Nirmala Bhogal; Robert Combes
Journal:  Altern Lab Anim       Date:  2006-05       Impact factor: 1.303

10.  Generation of functional human hepatic endoderm from human induced pluripotent stem cells.

Authors:  Gareth J Sullivan; David C Hay; In-Hyun Park; Judy Fletcher; Zara Hannoun; Catherine M Payne; Donna Dalgetty; James R Black; James A Ross; Kay Samuel; Gang Wang; George Q Daley; Je-Hyuk Lee; George M Church; Stuart J Forbes; John P Iredale; Ian Wilmut
Journal:  Hepatology       Date:  2010-01       Impact factor: 17.425

View more
  1 in total

Review 1.  Adverse Outcome Pathways and Drug-Induced Liver Injury Testing.

Authors:  Mathieu Vinken
Journal:  Chem Res Toxicol       Date:  2015-07-02       Impact factor: 3.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.